A global repository for research into the collateral effects of the COVID-19 lockdown measures.
The three GBD authors plus Prof Carl Heneghan of CEBM have launched a new website collateralglobal.org, “a global repository for research into the collateral effects of the COVID-19 lockdown measures”. Follow Collateral Global on Twitter here.
The aim of Collateral Global is to provide a resource for scholarship and research into the collateral effects of responses to the COVID-19 pandemic.
There are two main facets to this:
On the one hand we need to understand how effective the response strategies to COVID-19 have been against their original objectives, and on the other hand to build an understanding of the effect of these strategies on public health, the economy and how people live their lives.
Our aim is to gather this information from around the world and provide the data, research and other supporting material as a resource to inform public policy in the years ahead.
The www.collateralglobal.org web site is owned and managed by Collateral Global Ltd., which is a nonprofit company incorporated in the UK and Wales on 4th November 2020, Company number 12998042. The company is run on a strictly not for profit basis in accordance with its objects.
The supervisory board currently comprises:
- Dr. Jay Bhattacharya, Professor of Medicine, senior fellow at the Stanford Institute for Economic Policy Research
- Dr. Sunetra Gupta, Professor of Theoretical Epidemiology, University of Oxford
- Dr. Carl Heneghan, Professor of Evidence Based Medicine, University of Oxford
- Dr. Martin Kulldorff, Professor, Medicine, Harvard Medical School.
Funding of Collateral Global Ltd. is via private donation.
If you wish to donate, please visit our donation page or contact firstname.lastname@example.org.